ReviewBiomolecules2026
TIF1 Family Proteins as Modulators of Cell Death: Mechanisms and Therapeutic Opportunities.
Review in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Regulated cell death is essential for development, tissue homeostasis, host defense, and disease. Beyond apoptosis, it is now clear that other forms of cell death, including ferroptosis, pyroptosis, and necroptosis, also contribute to pathology, often in interconnected rather than isolated ways. Within this broader framework, the transcriptional intermediary factor 1 (TIF1) family, comprising TRIM24, TRIM28, TRIM33, and TRIM66, has emerged as an important group of regulators linking stress adaptation, cell-state control, and cell death susceptibility. Although these proteins belong to the same family, they influence cell death through distinct and context-dependent mechanisms. Across the TIF1 family, apoptosis is by far the most extensively studied cell death phenotype, whereas links to ferroptosis, pyroptosis, and necroptosis remain more limited, more context dependent, and more unevenly distributed across individual members. Cell death often becomes evident when TIF1-dependent stress-buffering programs are disrupted, highlighting both their biological importance and potential therapeutic relevance. At the same time, family-level differences are emerging, while the underlying mechanisms remain incompletely understood, and recent advances in this field have not been synthesized. This review summarizes how TIF1 family members intersect with different cell death programs, discusses emerging translational opportunities and challenges, and highlights key mechanistic questions for future study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.